Nuvation will launch two new studies of safusidenib in glioma, a global pivotal trial and a Phase II trial in the US.

A form of glioma, a type of brain cancer, tends to progress toward greater malignancy due to an increasing tendency of glioma ...

Having performed more than 7,500 complex brain surgeries, Dr. Aaron Cohen-Gadol helped pioneer fluorescence-guided surgical ...

Glioma research has rapidly evolved in recent years, particularly in the context of diagnostic imaging and personalized ...

The long-term results from the clinical trial saw patients survive well past the usual survival time for these types of tumors.

Pediatric high-grade gliomas, particularly H3K27M diffuse midline gliomas (DMG), are aggressive malignant brain tumors with a poor prognosis. Previous research suggests that platelet-derived growth ...

The US Food and Drug Administration (FDA) has approved vorasidenib (Voranigo, Servier) for the treatment of certain isocitrate dehydrogenase (IDH)–mutant diffuse gliomas, marking the first approval of ...

About one-third of all brain tumors are gliomas, cancerous growths that originate in the glial cells that surround and support neurons in the brain. The prognosis for patients with gliomas is not good ...